Background:
This study aims to explore the clinical utility of Evolocumab in combination with an e-Health System: Swiss Prospective
Observational Study in Patients with clinical Atherosclerotic Cardiovascular Disease.
Sponsor: Amgen, Switzerland
Trial Status:
recruiting
Enrolling Centers:
Switzerland
Core Study Team:
ECARA